ICON PLC

ICLR · XNAS

CIK 1060955fmd_1MPM058CTCSFQEXCF2NEYX1GBVServices · Services-Commercial Physical & Biological ResearchTemplate: Standard

Coverage: Jan 01, 2008 to Sep 30, 2026, 69 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	1,666	1,758	2,596	2,806	2,797	5,481	7,741	8,055	8,189	8,251
Cost of revenue	961	1,027	1,818	1,974	1,980	3,973	5,527	5,720	5,845	–
Gross profit	705	731	778	832	817	1,508	2,214	2,335	2,344	–
Selling, general and administrative	326	324	326	333	342	585	779	769	728	780
Operating income	312	338	373	433	392	379	795	905	1,032	443
Interest expense	13	13	14	13	13	182	230	337	237	197
Interest and investment income	1	2	5	7	3	1	2	5	9	7
Income before taxes	300	328	365	427	381	197	568	573	804	252
Income tax expense	38	47	42	51	48	41	59	18	65	23
Net income from continuing operations	262	281	323	376	333	155	508	555	739	229
Net income	262	281	323	374	332	153	505	554	739	229
Net income to common shareholders	–	281	323	369	328	153	505	–	–	–